News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
699,967 Results
Type
Article (39740)
Company Profile (248)
Press Release (659979)
Multimedia
Podcasts (51)
Webinars (12)
Section
Business (204186)
Career Advice (2008)
Deals (35420)
Drug Delivery (95)
Drug Development (81057)
Employer Resources (172)
FDA (16189)
Job Trends (14864)
News (345230)
Policy (32547)
Tag
Academia (2554)
Accelerated approval (5)
Adcomms (20)
Allergies (86)
Alliances (49444)
ALS (95)
Alzheimer's disease (1383)
Antibody-drug conjugate (ADC) (132)
Approvals (16187)
Artificial intelligence (264)
Autoimmune disease (22)
Automation (17)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (176)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (290)
Cancer (2316)
Cardiovascular disease (179)
Career advice (1677)
Career pathing (30)
CAR-T (155)
Cell therapy (435)
Cervical cancer (20)
Clinical research (66090)
Collaboration (856)
Company closure (2)
Compensation (565)
Complete response letters (19)
COVID-19 (2591)
CRISPR (41)
C-suite (250)
Cystic fibrosis (102)
Data (2322)
Decentralized trials (2)
Denatured (19)
Depression (44)
Diabetes (275)
Diagnostics (6379)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (103)
Drug shortages (25)
Duchenne muscular dystrophy (96)
Earnings (87044)
Editorial (39)
Employer branding (21)
Employer resources (146)
Events (112648)
Executive appointments (741)
FDA (17566)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (768)
Gene editing (109)
Generative AI (20)
Gene therapy (313)
GLP-1 (719)
Government (4431)
Grass and pollen (4)
Guidances (158)
Healthcare (18820)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (124)
Indications (29)
Infectious disease (2736)
Inflammatory bowel disease (143)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (98)
Interviews (312)
IPO (16526)
IRA (40)
Job creations (3633)
Job search strategy (1422)
Kidney cancer (10)
Labor market (43)
Layoffs (476)
Leadership (17)
Legal (7910)
Liver cancer (76)
Lung cancer (325)
Lymphoma (157)
Machine learning (9)
Management (58)
Manufacturing (324)
MASH (77)
Medical device (13383)
Medtech (13388)
Mergers & acquisitions (19467)
Metabolic disorders (707)
Multiple sclerosis (83)
NASH (16)
Neurodegenerative disease (94)
Neuropsychiatric disorders (27)
Neuroscience (1939)
NextGen: Class of 2025 (6512)
Non-profit (4480)
Now hiring (40)
Obesity (371)
Opinion (205)
Ovarian cancer (81)
Pain (91)
Pancreatic cancer (88)
Parkinson's disease (152)
Partnered (22)
Patents (244)
Patient recruitment (115)
Peanut (46)
People (57343)
Pharmaceutical (63)
Pharmacy benefit managers (19)
Phase I (20593)
Phase II (29111)
Phase III (21674)
Pipeline (1367)
Policy (147)
Postmarket research (2563)
Preclinical (8759)
Press Release (64)
Prostate cancer (108)
Psychedelics (30)
Radiopharmaceuticals (247)
Rare diseases (384)
Real estate (5907)
Recruiting (65)
Regulatory (22327)
Reports (47)
Research institute (2320)
Resumes & cover letters (349)
Rett syndrome (6)
RNA editing (5)
RSV (42)
Schizophrenia (72)
Series A (131)
Series B (87)
Service/supplier (11)
Sickle cell disease (52)
Special edition (16)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3580)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (50)
The Weekly (30)
Vaccines (700)
Venture capitalists (42)
Weight loss (237)
Women's health (36)
Worklife (16)
Date
Today (189)
Last 7 days (964)
Last 30 days (3126)
Last 365 days (32530)
2025 (11860)
2024 (35219)
2023 (40077)
2022 (51173)
2021 (55710)
2020 (54084)
2019 (46538)
2018 (35018)
2017 (32110)
2016 (31481)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (718)
Alabama (54)
Alaska (7)
Arizona (233)
Arkansas (13)
Asia (37883)
Australia (6192)
California (6407)
Canada (2065)
China (539)
Colorado (274)
Connecticut (280)
Delaware (158)
Europe (81396)
Florida (956)
Georgia (215)
Idaho (57)
Illinois (546)
India (25)
Indiana (322)
Iowa (11)
Japan (171)
Kansas (106)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (922)
Massachusetts (4763)
Michigan (225)
Minnesota (404)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (68)
New Hampshire (63)
New Jersey (1793)
New Mexico (28)
New York (1804)
North Carolina (988)
North Dakota (8)
Northern California (2826)
Ohio (210)
Oklahoma (14)
Oregon (34)
Pennsylvania (1427)
Puerto Rico (13)
Rhode Island (33)
South America (1097)
South Carolina (25)
South Dakota (1)
Southern California (2407)
Tennessee (105)
Texas (950)
United States (24006)
Utah (188)
Virginia (151)
Washington D.C. (64)
Washington State (565)
West Virginia (3)
Wisconsin (56)
699,967 Results for "vaxart inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Vaccines
HHS Unfreezes Vaxart’s COVID-19 Study, Resumes Funding as Headwinds Batter Vaccines Space
While Vaxart can proceed with its study, fellow COVID-19 vaccine developers GeoVax and Novavax continue to be hamstrung by various regulatory roadblocks.
April 29, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Vaxart to Present at the Citizens Life Sciences Conference
May 1, 2025
·
1 min read
Press Releases
Vaxart CEO Issues Letter to Stockholders Highlighting Company Progress
May 5, 2025
·
8 min read
Press Releases
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 27, 2025
March 28, 2025
·
2 min read
Press Releases
Vaxart to Present at World Vaccine Congress Washington 2025 on April 23
April 16, 2025
·
1 min read
Press Releases
Vaxart Completes Enrollment in Phase 1 Trial for its Norovirus Oral Pill Vaccine Candidate
April 30, 2025
·
6 min read
Press Releases
Vaxart to Host First Quarter 2025 Business Update and Financial Results Conference Call on May 13
May 2, 2025
·
1 min read
Press Releases
Vaxart Provides Business Update and Reports Full Year 2024 Financial Results
March 20, 2025
·
12 min read
Press Releases
Vaxart Announces Clinical Trial Initiation of Norovirus Oral Pill Vaccine Candidate
March 12, 2025
·
5 min read
Biotech Bay
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 23, 2024
Vaxart, Inc. announced that on May 17, 2024, the Compensation Committee of the Board of Directors granted inducement equity awards covering an aggregate of 22,500 shares of its common stock to one new non-executive employee to induce him to accept employment with Vaxart.
May 23, 2024
·
2 min read
1 of 69,997
Next
